# A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants

> **NCT01615614** · PHASE1 · COMPLETED · sponsor: **Janssen R&D Ireland** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rilpivirine
- **DRUG:** Rifabutin

## Key facts

- **NCT ID:** NCT01615614
- **Lead sponsor:** Janssen R&D Ireland
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01615614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01615614, "A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01615614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*